专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

131. 发明申请

US20100070224A1 System and method for identifying appliances by electrical characteristics 审中-公开
公开(公告)号：US20100070224A1
公开(公告)日：2010-03-18
申请号：US12290672
申请日：2008-10-30
申请人： Roderick A. Hyde , Jordin T. Kare , Lowell L. Wood, JR.
发明人： Roderick A. Hyde , Jordin T. Kare , Lowell L. Wood, JR.
IPC分类号： G01R23/00 , G06F19/00
CPC分类号： G01R19/2513
摘要： Illustrative embodiments provide systems, applications, apparatuses, computer software program products, and methods related to identification of electrical appliances by electrical characteristics.

132. 发明申请

US20100070215A1 System and method for identifying appliances by electrical characteristics 审中-公开
公开(公告)号：US20100070215A1
公开(公告)日：2010-03-18
申请号：US12290682
申请日：2008-10-30
申请人： Roderick A. Hyde , Jordin T. Kare , Lowell L. Wood,, JR.
发明人： Roderick A. Hyde , Jordin T. Kare , Lowell L. Wood,, JR.
IPC分类号： G01R21/00
CPC分类号： G01R19/2513
摘要： Illustrative embodiments provide systems, applications, apparatuses, computer software program products, and methods related to identification of electrical appliances by electrical characteristics.

133. 发明申请

US20100069887A1 Multiple chamber ex vivo adjustable-release final dosage form 审中-公开
标题翻译：多室离体可调释最终剂型
公开(公告)号：US20100069887A1
公开(公告)日：2010-03-18
申请号：US12387324
申请日：2009-04-29
申请人： Mahalaxmi Gita Bangera , Edward S. Boyden , Roderick A. Hyde , Muriel Y. Ishikawa , Dennis J. Rivet , Elizabeth A. Sweeney , Lowell L. Wood, JR. , Victoria Y.H. Wood
发明人： Mahalaxmi Gita Bangera , Edward S. Boyden , Roderick A. Hyde , Muriel Y. Ishikawa , Dennis J. Rivet , Elizabeth A. Sweeney , Lowell L. Wood, JR. , Victoria Y.H. Wood
IPC分类号： A61M37/00
CPC分类号： A61K41/00 , A61K9/0009 , A61M37/00
摘要： Described embodiments include a final dosage form, an article of manufacture, and method. A described final dosage form includes a dosage portion having a chamber carrying a medicament. The dosage portion also has a release element in a first medicament-release state wherein the medicament has a first bioavailability to the animal. The release element is modifiable ex vivo to a second medicament-release state by an exposure to a stimulus, wherein the medicament has a second bioavailability to the animal. The final dosage form includes another dosage portion having another chamber carrying another medicament. The another dosage portion also has another release element in another first medicament-release state wherein the another medicament has another first bioavailability to the animal. The another release element is modifiable ex vivo to another second medicament-release state by an exposure to another stimulus, wherein the another medicament has another second bioavailability to the animal.
摘要翻译：描述的实施方案包括最终剂型，制品和方法。所描述的最终剂型包括具有携带药物的室的剂量部分。剂量部分还具有处于第一药物释放状态的释放元件，其中药物对动物具有第一生物利用度。释放元件通过暴露于刺激物离体修饰成第二药物释放状态，其中药物对动物具有第二生物利用度。最终剂型包括另一个剂量部分，其具有另一个容纳另一种药物的腔室。另一剂量部分还具有另一第一药物释放状态中的另一释放元件，其中另一种药物对动物具有另一种第一生物利用度。另一种释放元件可通过暴露于另一种刺激物离体修饰成另一种第二药物释放状态，其中另一种药物对动物具有另一种第二生物利用度。

134. 发明申请

US20100069821A1 Ex vivo modifiable medicament release-sites final dosage form 审中-公开
标题翻译：体外可修改的药物释放位点最终剂型
公开(公告)号：US20100069821A1
公开(公告)日：2010-03-18
申请号：US12387323
申请日：2009-04-29
申请人： Mahalaxmi Gita Bangera , Edward S. Boyden , Roderick A. Hyde , Muriel Y. Ishikawa , Dennis J. Rivet , Elizabeth A. Sweeney , Lowell L. Wood, JR. , Victoria Y.H. Wood
发明人： Mahalaxmi Gita Bangera , Edward S. Boyden , Roderick A. Hyde , Muriel Y. Ishikawa , Dennis J. Rivet , Elizabeth A. Sweeney , Lowell L. Wood, JR. , Victoria Y.H. Wood
IPC分类号： A61N1/30 , A61N5/00 , A61N7/00
CPC分类号： A61K9/0009 , A61K9/127
摘要： Described embodiments include a final dosage form, an article of manufacture, and method. A described final dosage form includes a dosage portion having a medicament, and a site and the medicament in a first association. In the first association, the medicament has a first bioavailability. The first association of the site and the medicament is modifiable ex vivo to a second association an exposure to a stimulus, wherein the medicament has a second bioavailability. The final dosage form includes another dosage portion having another medicament, and another site and the another medicament in another first association. In the another first association, the another medicament has another first bioavailability. The another first association is modifiable ex vivo to another second association of the another site and the another medicament by an exposure to another stimulus, wherein the another medicament has another second bioavailability.
摘要翻译：描述的实施方案包括最终剂型，制品和方法。所描述的最终剂型包括具有药物的剂量部分和第一结合中的部位和药物。在第一关联中，药物具有第一生物利用度。所述部位和所述药物的第一结合物可以离体修饰为暴露于刺激物的第二缔合，其中所述药物具有第二生物利用度。最终剂型包括具有另一种药物的另一剂量部分，另一个部位和另一个第一关联的另一药物。在另一个第一关联中，另一种药物具有另一种第一生物利用度。另一个第一关联可以通过暴露于另一种刺激离体修饰为另一个位点与另一种药物的另一第二缔合，其中另一种药物具有另一种第二生物利用度。

135. 发明申请

US20100068277A1 Ex vivo modifiable multiple medicament final dosage form 失效
标题翻译：体外可修改的多种药物最终剂型
公开(公告)号：US20100068277A1
公开(公告)日：2010-03-18
申请号：US12387325
申请日：2009-04-29
申请人： Mahalaxmi Gita Bangera , Edward S. Boyden , Roderick A. Hyde , Muriel Y. Ishikawa , Dennis J. Rivet , Elizabeth A. Sweeney , Lowell L. Wood, JR. , Victoria Y.H. Wood
发明人： Mahalaxmi Gita Bangera , Edward S. Boyden , Roderick A. Hyde , Muriel Y. Ishikawa , Dennis J. Rivet , Elizabeth A. Sweeney , Lowell L. Wood, JR. , Victoria Y.H. Wood
IPC分类号： A61K9/14
CPC分类号： G06F19/3456 , A61K9/06 , A61K9/127 , A61K9/4891 , A61K9/51 , G06F19/00
摘要： Described embodiments include a final dosage form for administering a medicament to an animal, an article of manufacture, and method. A described final dosage form includes a dosage portion having a medicament and a release element in a first medicament-release state. The medicament has a first bioavailability to the animal. The release element is modifiable ex vivo to a second medicament-release state by an exposure to a stimulus, wherein the medicament has a second bioavailability to the animal. The final dosage form includes another dosage portion having another medicament and another release element in another first medicament-release state. In the another first medicament-release state, the another medicament has another first bioavailability to the animal. The another release element is modifiable ex vivo to another second medicament-release state by an exposure to another stimulus, wherein the another medicament has another second bioavailability to the animal.
摘要翻译：描述的实施方案包括用于向动物施用药物的最终剂型，制品和方法。描述的最终剂型包括具有药物和处于第一药物释放状态的释放元件的剂量部分。药物对动物具有第一生物利用度。释放元件通过暴露于刺激物离体修饰成第二药物释放状态，其中药物对动物具有第二生物利用度。最终剂型包括具有另一药物的另一剂量部分和处于另一第一药物释放状态的另一释放元件。在另一第一药物释放状态中，另一种药物对动物具有另一种第一生物利用度。另一种释放元件可通过暴露于另一种刺激物离体修饰成另一种第二药物释放状态，其中另一种药物对动物具有另一种第二生物利用度。

136. 发明申请

US20100068275A1 Personalizable dosage form 审中-公开
标题翻译：个性化剂型
公开(公告)号：US20100068275A1
公开(公告)日：2010-03-18
申请号：US12284014
申请日：2008-09-16
申请人： Mahalaxmi Gita Bangera , Edward S. Boyden , Roderick A. Hyde , Muriel Y. Ishikawa , Dennis J. Rivet , Elizabeth A. Sweeney , Lowell L. Wood, JR. , Victoria Y.H. Wood
发明人： Mahalaxmi Gita Bangera , Edward S. Boyden , Roderick A. Hyde , Muriel Y. Ishikawa , Dennis J. Rivet , Elizabeth A. Sweeney , Lowell L. Wood, JR. , Victoria Y.H. Wood
IPC分类号： A61K9/14
CPC分类号： A61K9/0009 , A61K9/0068
摘要： Provided embodiments include a final dosage form, an article of manufacture, and a method. A method of fulfilling a request specifying a dose of a medicament for an individual animal includes choosing pursuant to the request an instance of a final dosage form that includes the medicament. The method also includes selecting a stimulus effective to change a medicament-release state of a release element of the final dosage form. The method further includes initiating an ex vivo exposure of the release element of the chosen instance of the final dosage form to the selected stimulus. The method further includes the release element configured in a first medicament-release state and changeable to a second medicament-release state upon an ex vivo exposure to a stimulus.
摘要翻译：所提供的实施方案包括最终剂型，制品和方法。满足指定用于个体动物的药物剂量的请求的方法包括根据请求选择包括药物的最终剂型的实例。该方法还包括选择有效改变最终剂型释放元件的药物释放状态的刺激物。该方法还包括将所选择的最终剂型实例的释放元件离体暴露于所选择的刺激物。该方法还包括在第一药物释放状态下配置的释放元件，并且在离体刺激刺激后可以变化到第二药物释放状态。

137. 发明申请

US20100068266A1 Ex vivo-modifiable multiple-release state final dosage form 审中-公开
标题翻译：离体可更新的多次释放状态最终剂型
公开(公告)号：US20100068266A1
公开(公告)日：2010-03-18
申请号：US12387326
申请日：2009-04-29
申请人： Mahalaxmi Gita Bangera , Edward S. Boyden , Roderick A. Hyde , Muriel Y. Ishikawa , Dennis J. Rivet , Elizabeth A. Sweeney , Lowell L. Wood, JR. , Victoria Y.H. Wood
发明人： Mahalaxmi Gita Bangera , Edward S. Boyden , Roderick A. Hyde , Muriel Y. Ishikawa , Dennis J. Rivet , Elizabeth A. Sweeney , Lowell L. Wood, JR. , Victoria Y.H. Wood
IPC分类号： A61K9/52 , A61K9/00 , A61K9/14 , A61P43/00
CPC分类号： G06F19/3456 , A61K9/06 , A61K9/127 , A61K9/4891 , A61K9/51
摘要： Described embodiments include a final dosage form for administering a medicament to an animal, an article of manufacture, and method. A described final dosage form includes a medicament. The final dosage form also includes a release-control substance carrying the medicament in a first medicament-release state wherein the medicament has a first bioavailability to the animal if the final dosage form is administered to the animal. The release-control substance is modifiable ex vivo by an exposure to a first stimulus to carry the medicament in a second medicament-release state wherein the medicament has a second bioavailability to the animal if the final dosage form is administered to the animal. The release-control substance is modifiable ex vivo by an exposure to second stimulus to carry the medicament in a third medicament-release state wherein the medicament has a third bioavailability to the animal if the final dosage form is administered to the animal.
摘要翻译：描述的实施方案包括用于向动物施用药物的最终剂型，制品和方法。所述最终剂型包括药物。最终剂型还包括在第一药物释放状态下携带药物的释放控制物质，其中如果向动物施用最终剂型，则药物对动物具有第一生物利用度。释放对照物质可以通过暴露于第一次刺激而离体修饰，以在第二药物释放状态下携带药物，其中如果将最终剂型施用于动物，则药物对动物具有第二生物利用度。释放对照物质可以通过暴露于第二次刺激而离体修饰，以在第三药物释放状态下携带药物，其中如果向动物施用最终剂型，则药物对动物具有第三生物利用度。

138. 发明申请

US20100068152A1 Ex vivo modifiable particle or polymeric based final dosage form 审中-公开
标题翻译：离体可修饰的基于颗粒或聚合物的最终剂型
公开(公告)号：US20100068152A1
公开(公告)日：2010-03-18
申请号：US12322877
申请日：2009-02-05
申请人： Mahalaxmi Gita Bangera , Edward S. Boyden , Roderick A. Hyde , Muriel Y. Ishikawa , Dennis J. Rivet , Elizabeth A. Sweeney , Lowell L. Wood, JR. , Victoria Y.H. Wood
发明人： Mahalaxmi Gita Bangera , Edward S. Boyden , Roderick A. Hyde , Muriel Y. Ishikawa , Dennis J. Rivet , Elizabeth A. Sweeney , Lowell L. Wood, JR. , Victoria Y.H. Wood
IPC分类号： A61K9/14 , A61K9/10 , A61K9/127
CPC分类号： A61K9/127 , A61K9/1629
摘要： Provided embodiments include a final dosage form, an article of manufacture, and method. A final dosage form for administering a medicament to an animal is provided. The final dosage form includes the medicament, and a particle or polymeric material. The particle or polymeric material carries the medicament and is configured in a medicament-retention state. In medicament-retention state, the medicament is substantially not bioavailable to the animal if the final dosage form is administered to the animal. The particle or polymeric material is modifiable ex vivo by an exposure to a stimulus to a medicament-release state. In the medicament-release state, the medicament is substantially bioavailable to the animal if the final dosage form is administered to the animal.
摘要翻译：提供的实施方案包括最终剂型，制品和方法。提供了用于向动物施用药物的最终剂型。最终剂型包括药物和颗粒或聚合物材料。颗粒或聚合物材料携带药物并且被配置为药物保持状态。在药物保留状态下，如果向动物施用最终剂型，则药物基本上不能对动物生物利用。通过暴露于药物释放状态的刺激，粒子或聚合物材料可以离体修饰。在药物释放状态下，如果向动物施用最终剂型，则药物对动物基本上是生物利用的。

139. 发明申请

US20100056214A1 Application control based on flexible interface conformation sequence status 有权
标题翻译：基于灵活接口构造顺序状态的应用程序控制
公开(公告)号：US20100056214A1
公开(公告)日：2010-03-04
申请号：US12456501
申请日：2009-06-16
申请人： Alexander J. Cohen , Edward K.Y. Jung , Royce A. Levien , Richard T. Lord , Robert W. Lord , Mark A. Malamud , John D. Rinaldo, JR.
发明人： Alexander J. Cohen , Edward K.Y. Jung , Royce A. Levien , Richard T. Lord , Robert W. Lord , Mark A. Malamud , John D. Rinaldo, JR.
IPC分类号： G09G5/00 , H04M1/00
CPC分类号： G06F3/017 , G06F1/1615 , G06F1/1626 , G06F1/1641 , G06F1/1647 , G06F1/1652 , G06F1/1656 , G06F1/1677 , G06F1/1684 , H04M1/0268
摘要： A system includes, but is not limited to: one or more conformation sensor modules configured to direct obtaining information associated with one or more changes in one or more sequences of two or more conformations of one or more portions of one or more regions of the flexible interface and one or more coordination modules configured to direct coordinating the one or more changes in one or more sequences of two or more conformations of one or more portions of one or more regions of the flexible interface with one or more commands. In addition to the foregoing, other related method/system aspects are described in the claims, drawings, and text forming a part of the present disclosure.
摘要翻译：系统包括但不限于：一个或多个构象传感器模块，其被配置为指导获得与灵活的一个或多个区域的一个或多个部分的两个或多个部分的两个或更多个构型的一个或多个序列中的一个或多个序列的一个或多个变化相关联的信息接口和一个或多个协调模块，其被配置为将柔性接口的一个或多个区域的一个或多个部分的一个或多个部分的一个或多个构造的一个或多个序列的一个或多个序列与一个或多个命令进行协调。除了上述之外，在构成本公开的一部分的权利要求，附图和文本中描述了其他相关方法/系统方面。

140. 发明申请

US20100053067A1 E-paper display control of classified content based on e-paper conformation 有权
标题翻译：基于电子纸构图的电子纸显示分类内容的控制
公开(公告)号：US20100053067A1
公开(公告)日：2010-03-04
申请号：US12284340
申请日：2008-09-19
申请人： Alexander J. Cohen , Edward K.Y. Jung , Royce A. Levien , Robert W. Lord , Mark A. Malamud , John D. Rinaldo, JR.
发明人： Alexander J. Cohen , Edward K.Y. Jung , Royce A. Levien , Robert W. Lord , Mark A. Malamud , John D. Rinaldo, JR.
IPC分类号： G09G3/34
CPC分类号： G09G3/2092 , G09G3/3433 , G09G2380/02
摘要： A method for one or more portions of one or more regions of an electronic paper assembly having one or more display layers includes, but is not limited to: one or more conformation sensor modules configured to direct acquisition of first information associated with one or more conformations of one or more portions of one or more regions of the electronic paper assembly and one or more multi-layer display control modules configured to direct control of display of one or more portions of one or more display layers of the electronic paper assembly regarding display of second information having one or more classifications in response to the first information associated with the one or more conformations of the one or more portions of the one or more regions of the electronic paper assembly. In addition to the foregoing, other related method/system aspects are described in the claims, drawings, and text forming a part of the present disclosure.
摘要翻译：具有一个或多个显示层的电子纸组件的一个或多个区域的一个或多个区域的一个或多个部分的方法包括但不限于：一个或多个构造传感器模块，被配置为直接获取与一个或多个构象相关联的第一信息电子纸组件的一个或多个区域的一个或多个部分以及一个或多个多层显示控制模块，其被配置为直接控制电子纸组件的一个或多个显示层的一个或多个部分的显示，第二信息响应于与电子纸组件的一个或多个区域的一个或多个部分的一个或多个部分的一个或多个构造相关联的第一信息具有一个或多个分类。除了上述之外，在构成本公开的一部分的权利要求，附图和文本中描述了其他相关方法/系统方面。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式